■2019年冠状病毒病(COVID-19)的突然爆发使世界各地的人们陷入了痛苦的深渊。当时,目前尚无明确有效的治疗方法。我们准备了一个由重症监护专家组成的医疗队,呼吸系统疾病,感染,胃肠病学,内分泌学,心脏病学,脑血管疾病,肾脏病学,康复,心理学,和营养。这项研究分享了我们在治疗COVID-19患者方面的多学科治疗经验。
■SARS-CoV-2拭子试验阳性的患者分为三组:普通病例,严重病例和危重病例。每位患者均根据患者的具体情况接受多学科综合、个性化的量身定制治疗。病人的医疗记录,流行病学,临床,实验室,放射学特征,Borg呼吸困难评分,Barthel指数,分析焦虑自评量表(SAS)以及治疗和结局数据.
■90例患者的平均年龄为61.88±15.25岁。一些没有基础疾病的患者出现了合并症,例如高血糖症(24,26.67%)和高血压(9,10%)。通过多学科个性化治疗,患者白蛋白水平和Barthel指数评分显著增加,而葡萄糖水平,血压,和2002年营养风险筛查(NRS-2002),博格秤,出院时SAS值显着下降。住院死亡率为4.44%。然而,营养风险筛查仍然存在差距,危重病例与出院时普通和重症病例之间的Borg呼吸困难评分和Barthel指数。我们观察到病情较重的患者年龄明显较高,高血压的发生率,和死亡率。出院患者的中位住院时间为19天[四分位距(IQR),9.0-20.0天]。
■多学科协作和个体化治疗可有效改善不同严重程度COVID-19患者的一般状况。
UNASSIGNED: The sudden outbreak of coronavirus disease 2019 (COVID-19) has brought people around the world into an abyss of suffering. At that time, there were no clear and effective means for the treatment of the virus. We prepared a medical team consisted of specialists in critical care, respiratory diseases, infections, gastroenterology, endocrinology, cardiology, cerebrovascular diseases, nephrology, rehabilitation, psychology, and nutrition. This study shared our multidisciplinary treatment experience in treating patients with COVID-19.
UNASSIGNED: Patients with positive SARS-CoV-2 swab test were divided into three groups: ordinary cases, severe cases and critical cases. Every patient received the multi-disciplinary comprehensive and individualized tailored treatment based on the specific situation of each patient. Patients\' medical records, epidemiological, clinical, laboratory, radiological characteristics, Borg dyspnea score, Barthel index, self-rating anxiety scale (SAS) as well as treatment and outcome data were analyzed.
UNASSIGNED: The mean age of the 90 patients was 61.88±15.25 years. Some patients without underlying disease had developed comorbidities such as hyperglycemia (24, 26.67%) and hypertension (9, 10%). With multidisciplinary individualized treatment, the patients\' albumin level and Barthel index score increased significantly, while glucose level, blood pressure, and Nutrition Risk Screening 2002 (NRS-2002), Borg scale, and SAS values significantly decreased at discharge. The in-hospital mortality rate was 4.44%. However, there was still a gap in Nutrition Risk Screening, Borg dyspnea score and Barthel index between the critical cases and the ordinary and severe cases at discharge. We observed that the patients with more severe disease had significantly higher age, rates of hypertension, and mortality. The median hospitalization time of discharged patients was 19 days [interquartile range (IQR), 9.0-20.0 days].
UNASSIGNED: Multidisciplinary collaboration and individualized treatment could effectively improve the general status of patients with different severity of COVID-19.